PDSB PDS Biotechnology Corporation
8,039
$3.45
$0.065
(1.85%)
| Watchers | 8,039 |
| 52-Wk Low | $2.59 |
| 52-Wk High | $10.27 |
| Market Cap | $128.74M |
| Volume | 425,031.00 |
| 52-Wk High | $10.27 |
| 52-Wk Low | $2.59 |
PDS Biotechnology (PDSB, $4.02) RSI Indicator left the oversold zone on April 01, 2024Tickeron - Stocks • about 1 month ago
This is a signal that PDSB's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Share to Feed
PDS Biotechnology (NASDAQ:PDSB - Get Free Report)s stock had its "buy" rating reiterated by analysts at B. Riley in a note issued to investors on Thursday, Benzinga reports. They presently...
PDS Biotechnology Co. (NASDAQ:PDSB Free Report) Analysts at B. Riley issued their Q1 2024 EPS estimates for PDS Biotechnology in a note issued to investors on Thursday, March 28th. B...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
In a report released today, Robert LeBoyer from Noble Financial maintained a Buy rating on PDS Biotechnology (PDSB Research Report), with a price...
Analyst Mayank Mamtani of B.Riley Financial reiterated a Buy rating on PDS Biotechnology (PDSB Research Report), with a price target of $11.00. M...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
This is a signal that PDSB's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Related Stocks: NAS:PDSB...
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript March 27, 2024
PDS Biotechnology Corporation isnt one of the 30 most popular stocks among hedge funds at the end of...